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Abstract
Introduction:  Central  areolar  choroidal  dystrophy  (CACD)  is  a  rare,  inherited  disease  that  can
lead to  profound  visual  disturbance.  It  is  characterized  by  atrophic  changes,  particularly  in  the
macula. Speciﬁc  genotypic  mutations  are  responsible  for  the  autosomal  dominant  form  of  this
disease. However,  there  is  a  distinct  retinal  dystrophy  that  combines  central  areolar  choroidal
dystrophy  with  autosomal  dominantly  inherited  drusen.  It  has  been  proposed  that  patients  with
a speciﬁc  mutation  in  the  peripherin/RDS  gene  may  manifest  a  combined  presentation.
Case report: Here  we  describe  a  case  of  a  patient  who  reported  with  signiﬁcantly  decreased
best-corrected  visual  acuity  of  ﬁfteen  years  of  duration  in  the  right  eye  more  than  the  left.
Dilated fundus  examination  found  macular  changes  that  were  consistent  with  central  areolar
choroidal dystrophy.  In  addition,  there  was  evidence  of  surrounding  congenital  drusen  through-
out the  arcades  of  both  eyes.  Electrodiagnostics,  optical  coherence  tomography,  and  fundus
ﬂuorescein  angiography  were  used  to  conﬁrm  the  diagnosis  of  CACD.
Conclusion:  Central  areolar  choroidal  dystrophy  normally  presents  without  drusen.  However,  in
patients  manifesting  a  speciﬁc  mutation,  central  areolar  choridal  dystrophy  may  present  in  con-
junction with  drusen.  It  appears  that  the  Arg142Trp  mutation  is  one  of  the  factors  predisposing
to drusen  formation.
©  2012  Spanish  General  Council  of  Optometry.  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
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Resumen
Introducción:  La  distroﬁa  coroidea  areolar  central  (DCAC)  es  una  enfermedad  rara  y  hered-
itaria, que  puede  originar  una  gran  alteración  visual.  Se  caracteriza  por  cambios  atróﬁcos,
particularmente  en  la  mácula.  Las  mutaciones  genotípicas  especíﬁcas  son  responsables  de  la
forma dominante  autosómica  de  esta  enfermedad.  Sin  embargo  existe  una  distroﬁa  retiniana
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diferente,  que  combina  la  distroﬁa  coroidea  areolar  central  con  las  drusas  autosómicas  domi-
nantes hereditarias.  Según  se  ha  propuesto,  los  pacientes  con  una  mutación  especíﬁca  del  gen
periferina-RDS  pueden  manifestar  una  presentación  combinada.
Informe  de  un  caso:  Describimos  aquí  el  caso  de  un  paciente  que  se  presentó  con  una  disminu-
ción considerable  de  la  agudeza  visual  mejor  corregida,  desde  hacía  quince  an˜os,  más  acusada
en el  ojo  derecho  que  en  el  izquierdo.  El  examen  del  fondo  de  ojo  bajo  dilatación  mostró  unos
cambios maculares  en  consistencia  con  una  distroﬁa  coroidea  areolar  central.  Además,  existía
evidencia  de  drusas  congénitas  circundantes  en  las  arcadas  de  ambos  ojos.  Se  utilizaron  elec-
trodiagnóstico,  tomografía  de  coherencia  óptica  y  angiografía  ﬂuoresceínica  del  fondo  de  ojo
para conﬁrmar  el  diagnóstico  de  DCAC.
Conclusión: La  distroﬁa  coroidea  areolar  central  se  presenta  normalmente  sin  drusas.  Sin
embargo,  en  pacientes  que  maniﬁestan  una  mutación  especíﬁca,  la  distroﬁa  coroidea  areo-
lar central  puede  presentarse  acompan˜ada  de  drusas.  Parece  que  la  mutación  Arg142Trp  es  uno
de los  factores  que  inﬂuyen  en  la  formación  de  drusas.
© 2012  Spanish  General  Council  of  Optometry.  Publicado  por  Elsevier  España,  S.L.  Todos  los
derechos  reservados.
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unremarkable  in  OU.  Optical  coherence  tomography  was
performed  in  ofﬁce.  On  OCT  examination  in  OD,  the  atrophic
macular  area  correlated  with  a  total  absence  of  the  outerBackground
Central  areolar  choroidal  dystrophy  (CACD)  is  a  hereditary
retinal  disorder  that  primarily  affects  the  macula.  In  the
early  stages,  there  is  subtle,  mottled  depigmentation  in
the  posterior  pole.  Ultimately,  the  depigmentation  enlarges
into  in  a  well-circumscribed  round  or  oval  area  of  atrophy
of  the  retinal  pigment  epithelium  (RPE)  and  choriocapil-
laris  in  the  center  of  the  macula.1,2 Patients  usually  become
symptomatic  in  the  3rd  to  4th  decade  when  a  ﬁne,  hardly
detectable,  mottling  of  the  RPE  leads  to  the  development
of  absolute  central  visual  scotomas.  Later,  between  the  4th
and  7th  decade  of  life,  progressive  macular  atrophy  leads
to  a  dramatic  decline  in  central  visual  acuity  and  severe
visual  disability.3,4 CACD  may  be  autosomal  dominant  or
recessive;  however,  autosomal-recessive  cases  are  rare.1
Although  CACD  has  a  genetic  basis,  sporadic  cases  have  been
reported.5
Autosomal-dominant  CACD  is  heterogeneous,  but  muta-
tions  in  the  peripherin/RDS  (peripherin-2  or  PRPH2)  gene
seem  to  be  the  most  common  cause.1,6 Seven  different
mutations  in  the  peripherin/RDS  have  been  described  in
autosomal-dominant  CACD.1,5 The  p.Arg142Trp  mutation
in  the  peripherin/retinal  degeneration  slow  (RDS)  gene  has
been  implicated  in  both  autosomal-dominant  CACD  and
dominant  drusen.2,7 However,  no  ﬂecks  or  drusen  are  typ-
ically  seen  in  CACD.7,8 Therefore,  the  expression  of  this
particular  mutation  is  not  common.
Case report
A  47-year-old  black  female  presented  with  a  chief  com-
plaint  of  decreased  vision  in  her  right  eye  (OD)  for  the  past
15  years.  Her  ocular  history  included  a  prior  episode  of
anterior  uveitis  in  the  OD  which  resolved  with  conventional
treatment.  Medical  history  was  remarkable  for  hyperten-
sion  and  type  2  non-insulin  dependent  diabetes  of  17  years
duration.  Her  systemic  medications  included  glyburide,  met-
formin,  and  lisinopril.  Her  family  history  was  remarkable  for
F
aiabetes,  hypertension,  and  glaucoma  in  her  mother.  Exam-
nation  revealed  best  corrected  visual  acuity  of  OD  20/200
nd  OS  20/25.  Pupillary  reactions  were  normal  and  there
as  no  restriction  of  gaze.  Visual  ﬁelds  were  full  to  ﬁnger
ounting.  The  intraocular  pressures  were  20  mmHg  in  OD  and
7  mmHg  in  OS.  Slit  lamp  evaluation  exhibited  nuclear  scle-
osis  and  cortical  cataracts  in  OU  with  a  posterior  subcap-
ular  cataract  in  OS.  Fundus  examination  was  signiﬁcant  for
 well-circumscribed  area  of  choroidal  and  retinal  pigment
pithelial  atrophy  involving  the  macula  in  OD,  and  overall
eographic  atrophic  changes  in  OS  (Figs.  1  and  2).  Drusenoid
eposits  surrounded  both  maculae.  The  optic  nerves  were
ink  with  distinct  margins  and  the  peripheral  fundus  wasigure  1  (Top)  Fundus  photo  OD  with  well-delineated,
trophic  macular  lesion  with  surrounding  drusenoid  deposits.
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Figure  2  (Top)  Fundus  photo  OS  with  drusenoid  deposits  sur-
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dounding  a  mottled,  irregular  macula.
etinal  layers  with  shadowing  into  the  choroid.  (Fig.  3A)
n  addition,  the  OCT  revealed  ‘‘lumpiness’’  at  the  level  of
he  retinal  pigment  epithelium,  consistent  with  the  heavy
rusenoid  deposition.  (Fig.  3B)  Based  on  clinical  appearance
nd  OCT,  a  tentative  diagnosis  of  CACD  was  made  and  the
ﬂ
s
igure  3  (A)  On  OCT  examination  in  OD,  the  atrophic  macular  ar
ith shadowing  into  the  choroid.  (B)  OCT  revealing  bumpiness  at  th
rusenoid deposits  seen  throughout  the  posterior  pole.J.  Rodman  et  al.
atient  was  sent  for  further  evaluation  including  ﬂuorescein
ngiography  and  electrodiagnostic  evaluation.
Both  a  ﬂash  electroretinogram  (fERG)  and  multifocal
lectroretinogram  (mfERG)  were  performed.  (Figs.  4--6)  The
ERG  ﬁndings  showed  normal  rod  responses  along  with  a  mild
eduction  in  the  photopic  response  amplitude  and  minimal
elay,  with  the  right  eye  affected  to  a  greater  degree.  These
ndings  are  consistent  with  the  most  common  fERG  pattern
normal  responses  overall  with  slightly  impaired  photopic
esponses)  seen  in  patients  with  central  areolar  choroidal
ystrophy.2,9 The  mfERG  ﬁndings  further  mapped  the  ampli-
ude  reduction  across  50◦ of  the  posterior  pole.  The  results
ndicated  a  loss  of  central  cone  population,  consistent  with
atient’s  loss  of  vision  in  both  eyes,  and  with  the  foveal
rea  response  signiﬁcantly  more  depressed  in  the  right  eye.
t  is  worth  noting  that  the  retinal  dysfunction  noted  with
er  mfERG  is  not  limited  to  the  demarcated  central  atrophic
etinal  areas,  but  expands  beyond  centrifugally.  This  ﬁnding
as  been  reported  in  the  literature  in  patients  with  cen-
ral  areolar  choroidal  dystrophy,  and  is  thought  to  reﬂect  a
ore  diffuse  retinal  involvement  relative  to  the  clinically
vident  morphological  changes.10,11 The  mfERG  is  able  to
etect  abnormalities  localized  in  the  macula,  and  is  there-
ore  a  very  useful  instrument  in  the  diagnosis  of  macular
ystrophies  such  as  CACD.11 It  is  also  useful  to  help  mapping
reas  of  visual  loss  in  patients  unable  to  perform  reliableFluorescein  angiography  revealed  small  areas  of  hyper-
uorescence  corresponding  to  the  RPE  atrophy  in  the  early
tages.  In  the  later  frames,  there  is  loss  of  choriocapillaris
ea  correlated  with  a  total  absence  of  the  outer  retinal  layers
e  level  of  the  retinal  pigment  epithelium  consistent  with  the
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Figure  4  fERG  shows  normal  scotopic  responses  OU  (dark-adapted  waveforms  above),  reduced  photopic  response  amplitudes  and
minimal delay  OU  (light-adapted  waveforms  above),  with  right  eye  30  Hz  ﬂicker  responses  slightly  reduced  compared  to  left  eye.
These ﬁndings  are  consistent  with  the  most  common  fERG  pattern  seen  in  patients  with  central  areolar  choroidal  dystrophy.
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Figure  5  OD  mfERG  ﬁndings  show  marked  1st  order  response  amplitude  reduction  across  the  central  retina  with  a  normal  to  trace
delay in  implicit  time.  Note  the  marked  central  response  amplitude  depression  in  the  foveal  zone,  however  the  retinal  dysfunction
noted in  the  mfERG  is  not  limited  to  the  demarcated  central  atrophic  area  as  can  be  seen  in  the  retinal  photo  (Figs.  1  and  2).
This ﬁnding  of  retinal  response  depression  on  mfERG  testing  extending  beyond  the  borders  of  the  ophthalmoscopic  lesions  has
been reported  in  patients  with  CACD,  and  is  thought  to  reﬂect  a  more  diffuse  retinal  involvement  relative  to  the  clinically  evident
morphological  changes.
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Figure  6  OS  mfERG  ﬁndings  showing  marked  1st  order  response  amplitude  reduction  across  the  central  retina  with  a  normal
implicit time.  While  signiﬁcantly  attenuated,  there  is  still  the  prese
this eye.nce  of  a  foveal  response  peak  consistent  with  the  better  VA  in
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Figure  7  The  early  frames  of  the  angiogram  indicate  hyperﬂuorescence  of  the  lesions  corresponding  to  RPE  atrophy.  The  later
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mrames show  loss  of  the  choriocapillaris  in  the  area  of  RPE  atrop
n  the  area  of  RPE  atrophy.  The  hard  drusen  can  be  dis-
inguished  as  small,  well-deﬁned,  hyperﬂuorescent  lesions
Fig.  7).
Several  clinical  entities  resemble  the  fundoscopic
ppearance  described  and  the  differential  diagnoses
ncluded  central  areolar  choroidal  dystrophy,  cone  dystro-
hy,  macular  degeneration,  and  Stargardt’s  Disease.  In  our
atient,  the  diagnosis  of  central  areolar  choroidal  dystro-
hy  was  made  by  clinical  evaluation,  ancillary  testing  and
y  exclusion.
iscussion
entral  Areolar  Choroidal  Dystrophy  was  initially  called  Cen-
ral  Senile  Areolar  Choroidal  Atrophy  by  Nettleship  in  1884.12
n  1939,  Sorsby  renamed  the  condition  Choroidal  Angio-
clerosis.  The  current  name  of  CACD  was  designated  after
he  inheritance  pattern  was  deemed  primarily  dominant.
ince  CACD  is  predominantly  an  autosomal  dominant  disor-
er  with  complete  or  almost  complete  penetrance,  almost
ll  people  carrying  the  peripherin/RDS  (Arg142Trp)  mutation
an  be  considered  potential  CACD  patients.5,7
f
r
mThe  hard  drusen  can  be  seen  as  tiny,  hyperreﬂective  lesions.
Central  areolar  choroidal  dystrophy  is  a  heterogeneous
rogressive  macular  dystrophy  that  primarily  affects  the
horiocapillaris.  Clinically,  it  presents  as  a  regional,  geo-
raphic  area  of  atrophy  involving  the  choroid  and  RPE.  Fine
ymmetric  mottling  of  the  RPE  in  the  macula  can  resem-
le  that  of  a  bulls-eye.13 Patients  are  initially  asymptomatic
ith  normal  visual  acuity.  Between  the  3rd  and  4th  decades,
he  area  may  begin  to  mirror  that  of  a  macular  coloboma.14
ver  time,  retinal  blood  vessels  begin  to  course  over  the
esion  and  sclera  becomes  visible.  Visual  acuity  may  drop
o  the  20/50  level  at  this  stage.13 As  the  patient  gets  older
5--6th  decade),  the  lesion  may  begin  to  spread  more  periph-
rally  leading  to  further  visual  disturbance.
Four  clinical  stages  of  the  disease  have  been  described.5
tage  1  is  characterized  by  subtle  focal  parafoveal  pigmen-
ary  RPE  changes  that  can  be  observed  ophthalmoscopically.
tage  2  would  appear  as  an  oval-to-round,  mildly  atrophic,
ypopigmented  area.  Stage  3  is  characterized  by  one  or
ore  patches  of  well-demarcated  RPE  atrophy  outside  theovea.  In  stage  4,  the  atrophic  area  involves  the  fovea  which
esults  in  a  profound  decrease  in  vision.
The  retinal  ﬁndings  seen  in  CACD  vary  and  range  from
inimal  RPE  changes  without  drusen  to  CACD  associated
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MCentral  areolar  choroidal  dystrophy  with  associated  domina
with  dominant  drusen.  Literature  on  similar  clinical  pre-
sentations  is  limited.  Klevering  et  al.7 report  on  an  entity
called  Zermatt  macular  dystrophy  which  affects  patients
in  their  late  teens  and  twenties  and  presents  with  drusen-
like  deposits  and  central  pigmentary  changes.  Focal  atrophic
defects  with  eventual  geographic  atrophy  and  severe  visual
loss  results  in  these  patients.  Interestingly,  this  macular
dystrophy  is  linked  to  a  mutation  in  the  Arg172Trp  muta-
tion  of  the  RDS/peripherin  gene  which  is  located  alongside
the  Arg142Trp  mutation  in  the  large  intradiscal  loop  D2  of
the  RDS/peripherin  protein.7,15 It  is  possible  that  drusen
and  CACD  are  variable  expressions  of  the  same  disease,  as
these  are  allelic  disorders  of  the  RDS/peripherin  gene.4,7
Mutations  in  the  peripherin/RDS  gene  have  also  been  linked
to  retinitis  pigmentosa,  progressive  macular  degeneration,
cone-rod  dystrophy,  and  pattern  dystrophy.7,16
Differential  diagnosis
Because  of  the  type  of  fundus  changes  seen  in  CACD,  dif-
ferential  diagnosis  can  be  quite  challenging.  Several  of
the  macular  dystrophies  can  present  with  symmetric  RPE
mottling,  bull’s  eye  maculopathy,  and  central  geographic
atrophy  mimicking  those  changes  seen  in  early  CACD.  Cone
dystrophy  presents  with  a  bull’s  eye  appearance  in  the
macula  appearing  as  a  central  reddish  circular  area  (pig-
ment  clumping),  which  is  surrounded  by  depigmented  areas.
It  can  be  autosomal  dominant  or  recessive  and  usually
presents  in  the  ﬁrst  to  second  decade  with  moderate  to
severe  vision  loss.  Fluorescein  angiography  will  show  win-
dow  defects  late  if  there  is  chorioretinal  atrophy  or  breaks.
Electrodiagnostic  testing  typically  demonstrates  a  moder-
ate  reduction  and  delay  of  the  b-wave  on  fERG  testing  and  a
normal  EOG.  CACD  will  have  a  normal  to  slightly  subnor-
mal  fERG  and  EOG.  Additionally,  with  mfERG  testing  the
implicit  time  in  CACD  is  normal  (as  in  our  patient)  or  mini-
mally  delayed,  this  is  in  contrast  to  a  more  moderate  delay  in
cone  dystrophy  patients.  The  differential  diagnosis  can  also
be  established  by  looking  for  the  presence  of  large  choroidal
vessels  that  characterize  CACD  and  are  rarely  encountered
in  cone  dystrophy.4,7
Late  stage  CACD  shares  similar  clinical  characteristics
with  atrophic  age-related  macular  degeneration  (AMD),  such
as  geographic  atrophy  and  drusen.17,18 Several  features  may
aid  in  distinguishing  between  the  two.  In  the  early  stages
of  CACD,  subtle  parafoveal  pigmentary  RPE  changes  with  or
without  the  presence  of  an  oval,  mildly  atrophic  hypopig-
mented  area  in  the  center  of  the  fovea  can  be  seen.  In  AMD,
there  is  usually  hard/soft  drusen  concentrated  in  the  mac-
ula,  or  hyperpigmentation.  The  geographic  atrophy  of  AMD
usually  arises  from  these  drusen  or  hyperpigmentation.18,19
In  all  but  the  initial  stage  of  CACD,  a  speckled  fundus  auto-
ﬂuorescence  (FAF)  pattern  that  is  sharply  demarcated  from
the  surrounding  retina,  regularly  oval  shaped  and  conﬁned
to  the  central  macula  is  observed.  Although  speckled  FAF
patters  have  been  described  in  AMD,  the  alterations  were
less  regularly  shaped,  less  well  demarcated,  and  often
extended  beyond  the  macula.20,21 Drusen  associated  with
CACD  show  intense  fundus  autoﬂuorescence,  whereas  those
drusen  seen  in  AMD  do  not.7,18,22 In  the  speckled  FAF  areas  in
CACD,  OCT  will  show  a  corresponding  disorganization  of  the
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hotoreceptors  and  a  loss  of  photoreceptor  outer  segments,
een  as  a  disruption  of  the  inner-outer  photoreceptor
unction  and  thinning  of  the  Outer  Nuclear  Layer.23 OCT  of
MD  may  also  exhibit  sub-RPE  deposits,  whereas  these  are
xtremely  rare  in  CACD.  The  atrophic  zones  in  geographic
trophy  were  are  highly  irregular  and  show  residual  material
n  Bruch’s  membrane.  In  contrast,  in  CACD  the  atrophic
reas  are  smooth  and  homogeneous.  The  higher  occurrence
f  sub-RPE  deposits  and  irregular  structure  of  retinal  layers
ithin  the  atrophic  lesion  in  AMD  patients  indicates  differ-
nt  pathogenic  mechanisms  for  CACD  and  AMD.  Choroidal
eovascularization  is  also  rare  in  CACD  due  to  the  absence  of
 functional  choriocapillaris  or  choroidal  vascular  system.22
esides  the  circumscribed  atrophic  lesions  that  characterize
he  late  stages  in  both  disorders,  drusen-like  deposits  have
een  described  in  a  limited  number  of  patients  with  CACD.
The  prevalence  of  end-stage  AMD  has  been  estimated  at
%  in  people  aged  over  65  years,  and  climbs  to  11%  in  those
ver  85  years  old.  Therefore,  young  patients  with  atrophic
esions  should  be  suspected  of  having  entities  other  than
MD  until  proven  otherwise.24
Two  angiographic  patterns  of  wet  AMD  have  been
escribed,  classic  and  occult  choroidal  neovascular  mem-
rane  (CNV).  Classic  CNV  shows  up  in  the  early  phase  as
 bright,  well  delineated  area  of  hyperﬂuorescence  which
ncreases  in  intensity  and  size  through  the  mid  and  late
rames.  This  is  due  to  progressive  leakage  of  the  dye  that
bscures  the  boundaries  of  the  CNV.  With  occult  CNV,  the
uorescein  pattern  varies  from  speckled  hyperﬂuorescence
nitially  with  persistence  of  leakage  in  later  frames  to  late
eakage  of  dye  at  the  level  of  the  RPE  in  the  late  phases
f  the  angiogram  (not  corresponding  to  the  area  of  the
NV).25
Stargardt’s  disease  or  fundus  ﬂavimaculatus  can  present
ith  an  array  of  fundus  changes  including  a  beaten-bronze
ppearance  to  the  macula  and  yellow,  ﬁsh-tail  shaped  ﬂecks
n  the  retina.  The  fERG  is  usually  normal  in  these  patients,
hile  the  mfERG  usually  reveals  markedly  reduced  focal
oveal  and  central  retinal  responses,  even  in  the  presence
f  normal  acuity.26 The  dominance  pattern  is  the  same  as
ACD.  In  Stargardt’s/fundus-ﬂavimaculatus,  the  macula  is
ottled;  whereby  with  CACD,  the  macula  is  excavated  and
trophic.  Additionally,  the  ﬁsh-tail  ﬂecks  seen  outside  the
acula  in  Stargardt’s  are  not  seen  in  CACD.  Early  on,  the
wo  entities  are  difﬁcult  to  differentiate.  However,  in  Star-
ardt’s  fundus  ﬂuorescein  angiography  will  exhibit  continual
acular  hyperﬂuorescence  and  mid-peripheral  involvement
ith  a  silent  choroid.25
Central  areolar  dystrophy  (CAD)  of  the  RPE  must  also  be
ifferentiated  from  CACD.  CAD  of  the  RPE  almost  exclusively
ffects  white  females.22 Visual  acuity  begins  to  be  compro-
ised  in  the  late  5th  to  early  6th  decade  of  life.  Fundus
ndings  are  similar,  however  CAD  of  the  RPE  is  usually  uni-
ateral  and  the  atrophic  changes  affect  the  RPE  and  the
horoid.18,25
anagementue  to  the  hereditary  nature  of  CACD,  it  is  crucial  to  educate
he  patient  and  refer  the  patient  for  genetic  counseling.
ow  vision  rehabilitation  can  be  especially  useful  in  affected
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atients.  Visual  acuity  prognosis  is  poor;  however,  periph-
ral  vision  is  preserved  so  mobility  can  be  fairly  maintained.
ven  though  management  options  are  scarce,  proper  diag-
osis  is  essential  in  order  for  these  patients  to  be  properly
ounseled.
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